Skip to content

Insider · CIK 0001575933

Owen Hughes

ceoofficerdirector

Files at XOMA (XOMA Royalty Corp), CCCC (C4 Therapeutics, Inc.). First filing Nov 13, 2024, latest May 21, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.3M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
XOMAsell 3
XOMA Royalty Corp
$651k
25,637 shares
-29%-
48Moderate
XOMAsell 2
XOMA Royalty Corp
$655k
21,881 shares
-38%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 18, 2025CCCC
C4 Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+35,500$0.00$035,500Jun 20, 2025
May 19, 2025XOMA
XOMA Royalty Corp
MOption exercise
Common Stock
+53,359$0.00$088,338May 21, 2025
May 20, 2025XOMA
XOMA Royalty Corp
SOpen-market sale
Common Stock
-25,637$25.38$651k62,701May 21, 2025
May 19, 2025XOMA
XOMA Royalty Corp
MOption exercise
Performance Stock Unitsderivative
-53,359$0.00$0168,281May 21, 2025
Nov 11, 2024XOMA
XOMA Royalty Corp
MOption exercise
Common Stock
+53,360$0.00$056,860Nov 13, 2024
Nov 13, 2024XOMA
XOMA Royalty Corp
SOpen-market sale
Common Stock
-21,881$29.95$655k34,979Nov 13, 2024
Nov 11, 2024XOMA
XOMA Royalty Corp
MOption exercise
Performance Stock Unitsderivative
-53,360$0.00$0221,640Nov 13, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Owen Hughes: insider trades and track record | InsiderTell